-
for therapy. In particular, the prospect of targeting RNA with small molecule modulators offers great promise for tackling currently challenging diseases. Traditional drug molecules have mainly been designed
-
on the development and application of quantitative models to characterize drug effects and disease progression in order to optimize treatment strategies or clinical trial designs. Pharmacometric models involve a
Searches related to computational drug design
Enter an email to receive alerts for computational-drug-design positions